Dr. George Oliviu Angheloiu, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 637 Ditz Dr, Manheim, PA 17545 Phone: 717-606-8096 Fax: 717-745-3835 |
News Archive
Just months after receiving FDA approval, natalizumab, a medication for the treatment of multiple sclerosis (MS) and other inflammatory disorders, was voluntarily withdrawn by its manufacturers after three patients developed a brain infection known as Progressive Multifocal Leukoencephalopathy (PML).
It's a familiar sight in the majority of young families: young children bent over a screen for hours, texting or gaming, lost in a digital world.
Noting that only about 200 of the nearly 7,000 diseases classified as rare currently have treatments, the National Organization for Rare Disorders (NORD) today called for a Food and Drug Administration (FDA) statement of policy on regulation of therapies for rare disorders.
University of Minnesota Medical School physician researchers studied hydroxychloroquine as a treatment to prevent COVID-19 for those with high-risk for exposure to the virus - health care workers.
As we approach World AIDS Day, life-saving funding is under attack from multiple fronts, and it couldn't come at a worse time. One of the world's biggest donors, the Global Fund to Fight AIDS, TB and Malaria canceled its next round of funding, because it couldn't secure enough donations.
› Verified 9 days ago